CASP3 and hepatocellular carcinoma: Using a caspase-3/7 assay kit, we found a 2.5-fold increase in caspase enzymatic activity in Huh7 cells expressing GFPDENV-2.M-31/41 and GFPYFV.M-31/41, consistent with their ability to trigger apoptosis in human hepatoma cells [6].